With one of the world’s largest libraries of human molecular data, and a platform to make that data accessible and useful, CytoReason is able to turn data into actionable biological insights for use in clinical and pre-clinical drug development programs. CytoReason’s cell-level models are used by some of the largest pharmaceutical companies, enabling them to discover and develop the right therapies for the right patients, at the right time.

Six of the world’s 10 largest drugmakers, including GlaxoSmithKline, Pfizer and Roche, are among the multinationals now using CytoReason’s AI technology to develop hundreds of drugs. They were joined this week by Swiss multinational Ferring Pharmaceuticals, which says it is collaborating with CytoReason to establish new treatment options for patients with inflammatory bowel disease.



For details please contact kamal.rabha@israeltrade.gov.il